Michal Lotem
Hadassah Medical Center
2 papers in the Anchorcite directory, published between 2011 and 2015, cited 10,634 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cutaneous Melanoma Detection and Management · 2 papers
- Melanoma and MAPK Pathways · 2 papers
Frequent co-authors
- Caroline Robert · 2 papers
- Jean‐Jacques Grob · 2 papers
- Jacob Schachter · 1 paper
- Georgina Venetia Long · 1 paper
- Ana Maria Arance · 1 paper
- Laurent Mortier · 1 paper
- ADIL I. DAUD · 1 paper
- Matteo Salvatore Carlino · 1 paper
Papers
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine · 2015 · 6,034 citations
BACKGROUND: The immune checkpoint inhibitor ipilimumab is the standard-of-care treatment for patients with advanced melanoma. Pembrolizumab inhibits the programmed cell death 1 (PD-1) immune checkpoint and has antitumor activity in patients with advanced melanoma. METHODS: In this randomized, controlled, phase…
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaNew England Journal of Medicine · 2011 · 4,600 citations
BACKGROUND: Ipilimumab monotherapy (at a dose of 3 mg per kilogram of body weight), as compared with glycoprotein 100, improved overall survival in a phase 3 study involving patients with previously treated metastatic melanoma. We conducted a phase 3 study…
Metadata from OpenAlex (CC0).